395 related articles for article (PubMed ID: 32516590)
1. Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer.
Shen Y; Wang X; Lu J; Salfenmoser M; Wirsik NM; Schleussner N; Imle A; Freire Valls A; Radhakrishnan P; Liang J; Wang G; Muley T; Schneider M; Ruiz de Almodovar C; Diz-Muñoz A; Schmidt T
Cancer Cell; 2020 Jun; 37(6):800-817.e7. PubMed ID: 32516590
[TBL] [Abstract][Full Text] [Related]
2. The renin angiotensin system regulates Kupffer cells in colorectal liver metastases.
Wen SW; Ager EI; Neo J; Christophi C
Cancer Biol Ther; 2013 Aug; 14(8):720-7. PubMed ID: 23792575
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the renin-angiotensin system inhibits growth of colorectal cancer liver metastases in the regenerating liver.
Koh SL; Ager EI; Costa PL; Malcontenti-Wilson C; Muralidharan V; Christophi C
Clin Exp Metastasis; 2014 Apr; 31(4):395-405. PubMed ID: 24442969
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effects of renin-angiotensin system inhibitors on T lymphocytes in mice with colorectal liver metastases.
Vallejo Ardila DL; Walsh KA; Fifis T; Paolini R; Kastrappis G; Christophi C; Perini MV
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32448803
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the Renin-Angiotensin System Improves Response to Neoadjuvant Therapy in Patients With Liver Metastasis of Colorectal Cancers.
Wirsik NM; Appel PC; Braun A; Strowitzki MJ; Schleussner N; Nienhüser H; Schneider M; Schmidt T
J Surg Res; 2024 Jun; 298():176-184. PubMed ID: 38621351
[TBL] [Abstract][Full Text] [Related]
6. Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies.
Lazaris A; Amri A; Petrillo SK; Zoroquiain P; Ibrahim N; Salman A; Gao ZH; Vermeulen PB; Metrakos P
J Pathol Clin Res; 2018 Jul; 4(3):184-192. PubMed ID: 29654716
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in the renin-angiotensin system predict response to bevacizumab in cancer patients.
Moreno-Muñoz D; de la Haba-Rodríguez JR; Conde F; López-Sánchez LM; Valverde A; Hernández V; Martínez A; Villar C; Gómez-España A; Porras I; Rodríguez-Ariza A; Aranda E
Eur J Clin Invest; 2015 Dec; 45(12):1325-32. PubMed ID: 26509357
[TBL] [Abstract][Full Text] [Related]
8. Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases.
Zheng Y; Zhou R; Cai J; Yang N; Wen Z; Zhang Z; Sun H; Huang G; Guan Y; Huang N; Shi M; Liao Y; Bin J; Liao W
Cancer Res; 2023 Nov; 83(21):3577-3592. PubMed ID: 37610655
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor effects of ONC201 in combination with VEGF-inhibitors significantly impacts colorectal cancer growth and survival in vivo through complementary non-overlapping mechanisms.
Wagner J; Kline CL; Zhou L; Khazak V; El-Deiry WS
J Exp Clin Cancer Res; 2018 Jan; 37(1):11. PubMed ID: 29357916
[TBL] [Abstract][Full Text] [Related]
10. A Comparative Study on the Memory-Enhancing Actions of Oral Renin-Angiotensin System Altering Drugs in Scopolamine-Treated Mice.
Ababei DC; Bild V; Ciobică A; Lefter RM; Rusu RN; Bild W
Am J Alzheimers Dis Other Demen; 2019 Aug; 34(5):329-336. PubMed ID: 31106575
[TBL] [Abstract][Full Text] [Related]
11. Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab.
Eefsen RL; Engelholm L; Willemoe GL; Van den Eynden GG; Laerum OD; Christensen IJ; Rolff HC; Høyer-Hansen G; Osterlind K; Vainer B; Illemann M
Int J Cancer; 2016 Apr; 138(7):1777-84. PubMed ID: 26510166
[TBL] [Abstract][Full Text] [Related]
12. Targeting Tissue Stiffness in Metastasis: Mechanomedicine Improves Cancer Therapy.
Zhang J; Reinhart-King CA
Cancer Cell; 2020 Jun; 37(6):754-755. PubMed ID: 32516585
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells.
Napoleone E; Cutrone A; Cugino D; Amore C; Di Santo A; Iacoviello L; de Gaetano G; Donati MB; Lorenzet R
Thromb Res; 2012 Jun; 129(6):736-42. PubMed ID: 22188725
[TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin system (RAS) blockade attenuates growth and metastatic potential of renal cell carcinoma in mice.
Araújo WF; Naves MA; Ravanini JN; Schor N; Teixeira VP
Urol Oncol; 2015 Sep; 33(9):389.e1-7. PubMed ID: 25595575
[TBL] [Abstract][Full Text] [Related]
15. Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients.
Nakayama I; Shinozaki E; Matsushima T; Wakatsuki T; Ogura M; Ichimura T; Ozaka M; Takahari D; Suenaga M; Chin K; Mizunuma N; Yamaguchi K
BMC Cancer; 2017 Jan; 17(1):38. PubMed ID: 28068936
[TBL] [Abstract][Full Text] [Related]
16. An exploratory biomarker study in metastatic tumors from colorectal cancer patients treated with bevacizumab.
Sclafani F; Rimassa L; Colombo P; Destro A; Stinco S; Lutman FR; Carnaghi C; Beretta G; Zanello A; Roncalli M; Giordano L; Santoro A
Int J Biol Markers; 2015 Feb; 30(1):e73-80. PubMed ID: 24980447
[TBL] [Abstract][Full Text] [Related]
17. Interactions of the renin-angiotensin system in colorectal cancer and metastasis.
Childers WK
Int J Colorectal Dis; 2015 Jun; 30(6):749-52. PubMed ID: 25592047
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival.
Paiva TF; de Jesus VH; Marques RA; da Costa AA; de Macedo MP; Peresi PM; Damascena A; Rossi BM; Begnami MD; de Lima VC
BMC Cancer; 2015 Sep; 15():643. PubMed ID: 26394830
[TBL] [Abstract][Full Text] [Related]
19. Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases.
Neo JH; Malcontenti-Wilson C; Muralidharan V; Christophi C
J Gastroenterol Hepatol; 2007 Apr; 22(4):577-84. PubMed ID: 17376054
[TBL] [Abstract][Full Text] [Related]
20. Hepatic tumor growth: target for angiogenesis inhibition?
Sarraf-Yazdi S; Mi J; Clary BM
World J Surg; 2005 Mar; 29(3):287-92. PubMed ID: 15706441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
